Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia: a Drug Safety Randomised Controlled Trial

NCT07044193 is registered in ClinicalTrials.gov with Tamas Vegh, MD as lead sponsor.

NCT NCT07044193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07044193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia: a Drug Safety Randomised Controlled Trial
Lead sponsor
Tamas Vegh, MD
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 26, 2025
Completion date
December 31, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blocking agents, residual neuromuscular block, reversal of neuromuscular blockade